Innovative research and clinical application of recombinant human interferon alpha1b in pediatrics (Vol-ume Ⅰ) / 国际儿科学杂志
International Journal of Pediatrics
; (6): 461-464, 2019.
Article
in Zh
| WPRIM
| ID: wpr-751491
Responsible library:
WPRO
ABSTRACT
Recombinant human interferonα1b (IFN-α1b) is the first internationally unique novel ge-netic engineering medicine in China. As a major interferon subtype with natural antiviral activity, IFN-α1b has high safety and broad-spectrum antiviral effect, so it has broad application prospects in the treatment of viral diseases. Chinese pediatric doctors have taken the lead globally in conducting clinical research of IFN-α1b in the treatment of respiratory syncytial virus ( RSV) pneumonia、 bronchiolitis、 hand-foot-mouth disease, her-petic angina、 viral diarrhea, etc. A series of clinical guidance and expert consensus have been published which are in line with China's national conditions. This article summarizes the innovative research of IFN-α1b and proposes common issues and potential application in pediatric clinical applications.
Full text:
1
Index:
WPRIM
Type of study:
Guideline
Language:
Zh
Journal:
International Journal of Pediatrics
Year:
2019
Type:
Article